Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry

References

• IARC. Cancer today; 2020. Available from: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1. Accessed November 12, 2021.
   Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• DaBlaCa-data. Annual report 2020, bladder cancer, Denmark. DaBlaCa-data; [ Updated February 26, 2021].
   Google Scholar
• Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-Muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71(3):447–461. doi:10.1016/j.eururo.2016.05.041
   PubMed Web of Science ®Google Scholar
• Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, Phase III multicenter study. J Urol. 2005;174(3):862–866. doi:10.1097/01.ju.0000169257.19841.2a
   PubMed Web of Science ®Google Scholar
• Fradet Y, Grossman HB, Gomella L, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a Phase III, multicenter study. J Urol. 2007;178(1):68–73. doi:10.1016/j.juro.2007.03.028
   PubMed Web of Science ®Google Scholar
• Schmidbauer JA, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171(1):135–138. doi:10.1097/01.ju.0000100480.70769.0e
   PubMed Web of Science ®Google Scholar
• DaBlaCa. National guidelines, bladder cancer. DaBlaCa; 2020.
   Google Scholar
• Green DA, Rink M, Cha EK, et al. Cost-effective treatment of low-risk carcinoma not invading bladder muscle. BJU Int. 2013;111(3 Pt B):E78–84. doi:10.1111/j.1464-410X.2012.11454.x
   Web of Science ®Google Scholar
• Svatek RS, Hollenbeck BK, Holmäng S, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–262. doi:10.1016/j.eururo.2014.01.006
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33. doi:10.1177/1403494811401482
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Danmarks Statestik. 2017. Available from: https://www.dst.dk/da/Statistik/nyheder-analyser-publ/Publikationer/VisPub?cid=21499. Accessed 4 May 2022.
   Google Scholar
• eSundhed. Documentation of the Danish national patient registry; 2016 [ Updated November 18, 2016].
   Google Scholar
• Frank LE. When an entire country is a cohort. Science. 2000;287(5462):2398–2399. doi:10.1126/science.287.5462.2398
   PubMed Web of Science ®Google Scholar
• Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish national pathology registry and data bank. Clin Epidemiol. 2010;2:51–56. doi:10.2147/CLEP.S9908
   PubMedGoogle Scholar
• DaBlaCa. Behandling og opfølgning af ikke-invasive blæretumorer (Ta tumorer og CIS). DaBlaCa; 2022 [ Updated May 6].
   Google Scholar
• Seed P. DIAGT: stata module to report summary statistics for diagnostic tests compared to true disease status. Stata J. 2002;4:21.
   Google Scholar
• Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209–212. doi:10.1080/01621459.1927.10502953
   Google Scholar
• STATA.com. Confidence intervals for means, proportions, and variances. STATA. Available from: https://www.stata.com/manuals/rci.pdf. Accessed May 6, 2022.
   Google Scholar
• Gammelager H, Christiansen CF, Johansen MB, Borre M, Schoonen M, Sørensen HT. Quality of urological cancer diagnoses in the Danish national registry of patients. Eur J Cancer Prev. 2012;21(6):545–551. doi:10.1097/CEJ.0b013e328351c680
   Web of Science ®Google Scholar
• Okorie CL, Gatsby E, Schroeck FR, Ould Ismail AA, Lynch KE. Using electronic health records to streamline provider recruitment for implementation science studies. PLoS One. 2022;17(5):e0267915. doi:10.1371/journal.pone.0267915
   Web of Science ®Google Scholar
• Broe MO, Jensen PB, Mattsson TO, Pottegård A. Validity of antineoplastic procedure codes in the Danish national patient registry: the case of colorectal cancer. Epidemiology. 2020;31(4):599–603. doi:10.1097/EDE.0000000000001208
   PubMed Web of Science ®Google Scholar
• Blichert-Hansen L, Nielsson MS, Nielsen RB, Christiansen CF, Norgaard M. Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish national patient registry: a short report. Clin Epidemiol. 2013;5:9–12. doi:10.2147/CLEP.S37763
   PubMedGoogle Scholar
• Lykke MR, Nielsen TK, Ebbensgaard NA, Zieger K. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis. Scand J Urol. 2015;49(3):230–236. doi:10.3109/21681805.2015.1019562
   PubMed Web of Science ®Google Scholar